Infections are a serious health concern worldwide, particularly in vulnerable populations 23 such as the immunocompromised, elderly, and young. Advances in metagenomic sequencing 24 availability, speed, and decreased cost offer the opportunity to supplement or replace culture-25 based identification of pathogens with DNA sequence-based diagnostics. Adopting metagenomic 26 analysis for clinical use requires that all aspects of the pipeline are optimized and tested, 27 including data analysis. We tested the accuracy, sensitivity, and resource requirements of 28 Centrifuge within the context of clinically relevant bacteria. Binary mixtures of bacteria showed 29 Centrifuge reliably identified organisms down to 0.1% relative abundance. A staggered mock 30 bacterial community showed Centrifuge outperformed CLARK while requiring less computing 31 resources. Shotgun metagenomes obtained from whole blood in three febrile neutropenia patients 32 showed Centrifuge could identify both bacteria and viruses as part of a culture-free workflow. 33 Finally, Centrifuge results changed minimally by eliminating time-consuming read quality 34 control and host screening steps. 35 36 37 AUTHOR SUMMARY 38 39 Immunocompromised patients, such as those with febrile neutropenia (FN), are 40 susceptible to infections, yet cultures fail to identify causative organisms ~80% of the time. 41 High-throughput metagenomic sequencing offers a promising approach for identifying pathogens 42 in clinical samples. Mining through metagenomes can be difficult given the volume of reads, 43 overwhelming human contamination, and lack of well-defined bioinformatics methods. The goal 44 of our study was to assess Centrifuge, a leading tool for the identification and quantitation of 45 microbes, and provide a streamlined bioinformatics workflow real-word data from FN patient 2 46 blood samples. To ensure the accuracy of the workflow we carefully examined each step using 47 known bacterial mixtures that varied by genetic distance and abundance. We show that 48 Centrifuge reliably identifies microbes present at just 1% relative abundance and requires 49 substantially less computer time and resource than CLARK. Moreover, we found that Centrifuge 50 results changed minimally by quality control and host-screening allowing for further reduction in 51 compute time. Next, we leveraged Centrifuge to identify viruses and bacteria in blood draws for 52 three FN patients, and confirmed suspected pathogens using genome coverage plots. We 53 developed a web-based tool in iMicrobe and detailed protocols to promote re-use. 54 3 55 INTRODUCTION 56 57 The current gold standard for clinical diagnosis of infections relies on isolating organisms 58 by culture-based methods followed by identification and drug resistance testing. Methods for 59 identifying pathogens that rely on culture have several drawbacks including fastidious bacteria, 60 the time required for growth in culture, and the difficulty targeting viruses, fungi, and parasites. 61 Identifying pathogens directly from biological samples by DNA sequencing can overcome the 62 above limitations of culture and may improve the rate and speed of diagnosis. For these reasons, 63 metagenomic shotgun sequencing of pathogens has been referred to as the holy grail of infection 64 diagnosis (Ecker et al., 2010). While culturing samples is the current standard for infection 65 diagnosis, it can have a high failure rate in some scenarios. For example, a study examined the 66 problem of culture-based diagnosis of infection in febrile neutropenia and found that only ~16% 67 (609 of 3,756) febrile neutropenia patients were culture positive (van Walraven & Wong, 2014).
While CLARK had nearly identical accuracy in relative abundance estimates as 164 Centrifuge (despite five positive identifications), there was a striking difference between the two 165 classification algorithms in the computation resources and time required to analyze the data.
166 Relative to CLARK, Centrifuge required less than a tenth of the memory and a quarter of the 167 runtime, while using half the number of central processing units (Table 1) . 
174
Pathogens were enriched using a simple sample preparation method from whole blood 175 samples drawn from three patients with febrile neutropenia, and the resulting metagenomic DNA 176 sequenced. Table 2 shows the starting number of raw reads and the percent passing through each 177 step from quality control, to host-screening by alignment, and finally Centrifuge analysis. The 178 reads classified by Centrifuge identified three likely pathogens: Pseudomonas fluorescens with a 179 relative abundance of 50.7% in patient 1, Human parvovirus with a relative abundance of 99.8% 180 in patient 2, and Torque teno virus in patient 3 with a relative abundance of 62.8% (Figure 3 ).
181 Comparing the percentages shown in Table 2 277 Figure 6A shows the relative amount of reads that were classified as human, microbial, or 278 unknown when the datasets were analyzed by Centrifuge without removing reads by alignment 279 to the human genome before analysis. The relative proportion of host (human) reads in the data 280 agreed well with the proportions found by alignment (see Table 2 ). While the proportion of host 281 DNA was less than in prior studies, suggesting that the enrichment for pathogen DNA used in 282 this study was successful, a significant proportion of the reads were still human.
283
Having established that a significant proportion of the reads in the datasets were of host 284 origin by both alignment and Centrifuge, we compared three approaches for removing host reads 285 in the febrile neutropenia patient data. These methods include (1) alignment to the human 286 genome and removal of aligned reads from the dataset, (2) removing the human sequence from 287 the reference database, and (3) using the "exclude TaxID" function in Centrifuge to exclude 288 reads from classification whose best match was to the human genome. Overall, exclusion of the 289 human genome from the reference database resulted in the highest number of reads classified to 290 the presumed pathogens; however, the differences between the methods were relatively minor 291 ( Figure 6B ). Patient 3, with a presumed pathogen of Torque Teno virus, showed the least effect 292 on the number of reads classified, with less than a 411 read difference (<1%) between the 293 number of reads classified between the three methods. In contrast, patient 2, with a presumed 316 approach that bypasses the issues of culture, however, mining the resulting metagenomic 317 sequence can be slow and error-prone given the volume of reads, host read contamination, and 318 lack of well-defined bioinformatics methods. The goal of our study was to assess Centrifuge, a 319 leading tool for identification and quantitation of metagenomic data, using clinically relevant 320 datasets to establish its accuracy in microbial/viral identification and abundance estimates with 321 an eye toward reducing compute time.
322
The first dataset used to assess Centrifuge was a series of binary bacterial mixtures 348 relative abundance estimates. A reasonable assumption would be that as phylogenetic distance 349 increases, the number of discriminatory k-mers increase to allow for better read classification by 350 Centrifuge. Instead, we observed high classification accuracy for the most closely related pair (E. 
358
We compared Centrifuge's performance against another leading k-mer based taxonomic 359 classifier, CLARK, in analyzing sequence data from a more complex community of 20 bacteria.
360 The mock community was also mixed in varying relative abundances as with the binary 361 mixtures, albeit, in a different range (~0.01-35%). Abundance calculations between the two 362 algorithms were nearly identical across the relative abundance range; however, the processing 363 time and computational resources for CLARK were greater (Table 1) . Also, CLARK had a 364 propensity for false positives, whereas Centrifuge did not. On the other hand, Centrifuge's results 365 had to be processed to account for the strain and phage-specific data generated. Such processing 366 would be a necessary part of adoption in a clinical setting, but Centrifuge's lack of false positives 367 and speed suggests it may be a good starting point for such a tool. Table 1 ). Users of Centrifuge may want to weigh the limited benefits of quality 411 controlling their data before analysis in Centrifuge versus the bias toward the removal of viral 412 reads and time required. Figure 6B ).
426
In contrast, when the human genome was removed from the Centrifuge database, reads from the 427 human genome derived from the ancestrally integrated parvovirus would have been misclassified 428 as Human Parvovirus B19, with the effect that it could inflate the relative abundance estimate.
429 The "exclude TaxID" method appears to offer a balance between the other two methods: it 430 allows both endogenous host reads and actual organism reads to be appropriately classified while 431 saving the time and computational cost of aligning reads to a host organism before analysis. 469 Samples were sequenced as described below, and the sequence data deposited to the NCBI 
